Department of Bacteriology, Faculty of Medical Sciences, Kyushu University, Fukuoka, Japan.
Department of Hematology, Tokyo Metropolitan Cancer and Infectious Diseases Center Komagome Hospital, Tokyo, Japan.
Microb Genom. 2022 May;8(5). doi: 10.1099/mgen.0.000830.
is an enterohepatic that causes bacteremia and other diseases in humans. While -like strains are isolated from animals, including dog isolates belonging to a recently proposed , little is known about the genetic differences between and these animal isolates. Here, we sequenced 43 or -like strains isolated from humans, hamsters, rats and dogs and collected 81 genome sequences of , and other enterohepatic strains from public databases. Genomic comparison of these strains identified four distinct clades (clades I-IV) in '' (HCCM) complex. Among these, clade I corresponds to and represents a human-adapted lineage in the complex. We identified several genomic features unique to clade I. They include the accumulation of antimicrobial resistance-related mutations that reflects the human association of clade I and the larger genome size and the presence of a CRISPR-Cas system and multiple toxin-antitoxin and restriction-modification systems, both of which indicate the contribution of horizontal gene transfer to the evolution of clade I. In addition, nearly all clade I strains but only a few strains belonging to one minor clade contained a highly variable genomic region encoding a type VI secretion system (T6SS), which could play important roles in gut colonization by killing competitors or inhibiting their growth. We also developed a method to systematically search for sequences in large metagenome data sets based on the results of genome comparison. Using this method, we successfully identified multiple HCCM complex-containing human faecal metagenome samples and obtained the sequence information covering almost the entire genome of each strain. Importantly, all were clade I strains, supporting our conclusion that is a human-adapted lineage in the HCCM complex.
是一种肠肝循环,可导致人类菌血症和其他疾病。虽然类似的菌株从动物中分离出来,包括属于最近提出的一个分类群的狗分离株,但人们对与这些动物分离株之间的遗传差异知之甚少。在这里,我们对 43 株或类似的从人类、仓鼠、大鼠和狗中分离的菌株进行了测序,并从公共数据库中收集了 81 株 、 和其他肠肝循环菌株的基因组序列。对这些菌株的基因组比较确定了 ''(HCCM)复合体中的四个不同的进化枝(进化枝 I-IV)。其中,进化枝 I 对应于 ,代表了该复合体中的一个人类适应性谱系。我们确定了几个独特于进化枝 I 的基因组特征。它们包括积累了与抗微生物药物耐药性相关的突变,这反映了进化枝 I 与人类的关联,以及更大的基因组大小和存在 CRISPR-Cas 系统和多个毒素-抗毒素和限制修饰系统,这两者都表明水平基因转移对进化枝 I 的进化做出了贡献。此外,几乎所有的进化枝 I 菌株都含有一个高度可变的基因组区域,该区域编码一种类型 VI 分泌系统(T6SS),而只有少数属于一个小进化枝的菌株含有该系统,该系统可能通过杀死竞争者或抑制其生长在肠道定植中发挥重要作用。我们还开发了一种基于基因组比较结果在大型宏基因组数据集系统中搜索 序列的方法。使用该方法,我们成功地从人类粪便宏基因组样本中鉴定出多个含有 HCCM 复合体的样本,并获得了几乎覆盖每个菌株全基因组的序列信息。重要的是,所有都是进化枝 I 菌株,这支持了我们的结论,即 是 HCCM 复合体中的一个人类适应性谱系。